Phytosterolemia in parenteral nutrition patients: implications for liver disease development.
about
The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patientsSteroidal compounds in commercial parenteral lipid emulsions.Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.Parenteral Lipid Tolerance and Adverse Effects: Fat Chance for Trouble?Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition.Home Parenteral Nutrition: Fat Emulsions and Potential Complications.Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutritionProceedings From FDA/A.S.P.E.N. Public Workshop: Clinical Trial Design for Intravenous Fat Emulsion Products, October 29, 2013.Prevention and treatment of intestinal failure-associated liver disease in children.The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis.Emergence of Mixed-Oil Fat Emulsions for Use in Parenteral Nutrition.Effect of an Olive Oil-Based Lipid Emulsion Compared With a Soybean Oil-Based Lipid Emulsion on Liver Chemistry and Bile Acid Composition in Preterm Infants Receiving Parenteral Nutrition: A Double-Blind, Randomized Trial.
P2860
Q33813004-E5C4B0AA-9289-4F05-82B3-2B91A1D754D8Q35809593-039CC318-8799-4170-8348-2535DCAD6E53Q36250280-D03581DE-F878-4D33-A5AB-5EEFAFD33D8FQ37296480-AC75C2C4-FFB6-43B5-9E4A-4BD4D6E93261Q38178585-07E8BBF6-0FA7-45BB-85E4-F69EEA30223EQ38547685-8C83A2B9-5425-42C8-A325-40E7702DB6B7Q38547689-B8556C4F-D2AD-447B-A183-A8738FC7FD22Q38930002-5FD84640-6B39-4AC0-AB8E-C36CE5DA7D63Q41060537-CFBAE430-376F-466A-9488-2BCB33E4D60EQ41726855-0196D0AA-2519-4341-AED5-BC344D809152Q42765644-B1025586-1A9A-4D9E-A5D4-EDC35620B863Q44698100-52DC9542-CE2D-4061-AA43-C2BA0EB756C8Q47435581-83A5DA43-12AC-4128-849E-56A93E89DF59Q53645486-5BF16592-53F1-42D8-A961-CD2D47B65CF1
P2860
Phytosterolemia in parenteral nutrition patients: implications for liver disease development.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Phytosterolemia in parenteral ...... for liver disease development.
@en
Phytosterolemia in parenteral ...... for liver disease development.
@nl
type
label
Phytosterolemia in parenteral ...... for liver disease development.
@en
Phytosterolemia in parenteral ...... for liver disease development.
@nl
prefLabel
Phytosterolemia in parenteral ...... for liver disease development.
@en
Phytosterolemia in parenteral ...... for liver disease development.
@nl
P2093
P1433
P1476
Phytosterolemia in parenteral ...... for liver disease development.
@en
P2093
Ana M Pita
Joan Solanich
Josep M Llop
José M Moreno-Villares
Maria Forga
Núria Virgili
Pilar García-Peris
Teresa Serrano
P304
P356
10.1016/J.NUT.2008.06.017
P577
2008-07-24T00:00:00Z